U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020873

Marketing Status: Prescription
Active Ingredient: BIVALIRUDIN
Proprietary Name: ANGIOMAX
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 250MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N020873
Product Number: 001
Approval Date: Dec 15, 2000
Applicant Holder Full Name: SANDOZ INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top